Pfizer Inc
NYSE: PFE
$26.04
-$0.06 (-0.2%)
Real Time Data Delayed 15 Min.
PFE Articles
While the polls have the race pretty tight, one thing is for sure: a victory by Donald Trump would favor a far different group of stocks than a victory by Hillary Clinton.
Published:
Last Updated:
The volatility in the markets have shaken some of the top dividend leaders and may be giving long-term investors a great buying opportunity.
Published:
Last Updated:
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
In a new research report, Baird notes two biotech companies in its research coverage universe that may be considered speculative takeover targets, and a third is a possible target as well.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
In one of the longest running bidding wars in recent times, Pfizer has finally reeled in cancer-drug maker Medivation.
Published:
Last Updated:
Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, nor do we know what price.
Published:
Last Updated:
August 17, 2016: Markets opened slightly lower Wednesday following a slide in European markets. Utility stocks were the leading sector while consumer discretionary stocks weighed most heavily. WTI...
Published:
Last Updated:
Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for each of its large cap pharmaceutical stocks.
Published:
Last Updated:
In the latest Merrill Lynch RIC Report, which is effectively a culmination of the firm's top research ideas, views and advice for clients, the one common theme throughout was where to find yields.
Published:
Last Updated:
The Dow Jones Industrial Average hit yet another all-time high on Thursday, August 11, 2016. What is amazing is that the rising tide did not actually lift all ships. There were over 20 companies...
Published:
Last Updated:
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
Published:
Last Updated:
The short interest data for the July 29 settlement date are out and it almost feels like short sellers are getting a bit panicked about the market rally.
Published:
Last Updated:
August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red for the rest of the day. The dollar gained strength this afternoon and crude oil...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.